The
slide to be stained for ER comprised
the following five tissues:
|
No. |
Tissue |
ER-positivity* |
ER-intensity* |
|
1. |
Uterine cervix
|
80-90 % |
Moderate to strong |
|
2. |
Breast ductal carcinoma |
Negative (<1 %) |
Negative |
|
3. |
Breast ductal carcinoma |
60-80 % |
Weak to moderate |
|
4. |
Breast ductal carcinoma |
60-80 % |
Weak to moderate |
|
5. |
Breast ductal carcinoma |
90-100 % |
Strong |
*ER-status and staining pattern as
characterized by NordiQC reference laboratories using the mAb clone
6F11 and the rmAb clone SP1.
All tissues were fixed in 10% neutral buffered formalin for 24 – 48
hours.
Criteria for assessing an ER staining as optimal included:
- A
moderate to strong, distinct nuclear staining of
both the columnar and squamous epithelial cells and most of the
stromal cells (with the exception of endothelial cells and
lymphoid cells) in the uterine cervix.
- An at least
weak to
moderate distinct nuclear staining of
the appropriate proportion of the neoplastic cells in the breast
ductal carcinomas no. 3
- 4.
- A strong distinct nuclear staining of
the appropriate proportion of the neoplastic cells in the breast
ductal carcinoma no. 5.
- No nuclear staining in the neoplastic
cells in the breast carcinoma no. 2 and no more than a weak cytoplasmic reaction
in cells with a strong nuclear staining.
124 laboratories participated in this
assessment. 81 % achieved a sufficient mark. The
antibodies (Abs) and marks are summarized in Table 1.
Table 1.
Abs and scores for ER, run B7
|
Concentrated Abs |
N |
Vendor |
Optimal |
Good |
Borderl. |
Poor |
Suff.1 |
Suff. OPS2 |
|
rmAb clone SP1 |
29
1
1
1 |
NeoMarkers
Dako
Diagnostic Biosystems
Master Diagnostica |
16 |
8 |
6 |
2 |
75 % |
80 % |
|
mAb clone 6F11 |
20
1 |
Novocastra
Sanova |
8 |
10 |
2 |
1 |
86 % |
100 % |
|
mAb clone 1D5 |
23
2
1 |
Dako
Zytomed
Immunovision |
0 |
16 |
8 |
2 |
62 % |
- |
|
mAb clones
1D5+6F11 |
1 |
NeoMarkers |
0 |
1 |
0 |
0 |
- |
- |
|
Ready-To-Use Abs |
|
|
|
|
|
|
|
|
|
rmAb clone SP1,
790-4324/25 |
30 |
Ventana |
27 |
3 |
0 |
0 |
100 % |
100 % |
|
rmAb clone SP1,
IR151 |
8 |
Dako |
3 |
3 |
2 |
0 |
75 % |
86 % |
|
rmAb clone SP1,
ZA0102 |
1 |
Zymed |
0 |
0 |
1 |
0 |
- |
- |
|
mAb clones 1D5
+ ER-2-123, K1904/SK310 |
2 |
Dako |
2 |
0 |
0 |
0 |
- |
- |
|
mAb clone 6F11
+ rmAb clone SP1, IP308/PM308 |
2 |
BioCare |
0 |
2 |
0 |
0 |
- |
- |
|
mAb clone 6F11,
760-2596 |
1 |
Ventana |
1 |
0 |
0 |
0 |
- |
- |
|
Total |
124 |
|
57 |
43 |
19 |
5 |
100 |
|
|
Proportion |
|
|
46 % |
35 % |
15 % |
4 % |
81 % |
92 % |
1) Proportion of sufficient stains
(optimal or good), 2) Proportion of sufficient stains with optimal
protocol settings only, see below.
Following central protocol parameters were used to obtain an optimal
staining:
Concentrated Abs
rmAb SP1: The protocols giving an optimal result were all based on
heat induced epitope retrieval (HIER) using Tris-EDTA/EGTA pH 9
(6/9)*, Target Retrieval Solution (TRS) pH 9 (EnVision FLEX TRS high pH,
Dako, (5/7), Cell Conditioning 1 (BenchMark, Ventana) (2/5),
EDTA/EGTA pH 8 (2/2)* or Citrate pH 6 (1/6) as retrieval buffer. The
rmAb was typically diluted in the range of 1:25– 1:250 depending on
the total sensitivity of the protocol employed. Using these protocol
settings 24 out of 30 (80 %) laboratories produced a sufficient
staining (optimal or good).
* (number of optimal results/number of laboratories using this
buffer)
mAb 6F11: the protocols giving an optimal result were all based on
HIER using Tris-EDTA/EGTA pH 9 (6/9), TRS pH 9 (EnVision FLEX TRS high pH,
Dako, (1/3), or Bond Epitope Retrieval Solution 2 (Bond, Leica)
(1/5) as retrieval buffer. The mAb was typically diluted in the
range of 1:20– 1:200 depending on the total sensitivity of the
protocol employed. Using these protocol settings 14 out of 14 (100
%) laboratories produced a sufficient staining (optimal or good).
Ready-To-Use Abs
rmAb clone SP1, prod. no 790-4324/25, Ventana: The
protocols giving an optimal result were all based on HIER using Cell
Conditioning 1, mild or standard, an incubation time of 16-32 min
in the primary Ab and iView or ultraView as the detection system.
Using these protocol settings all of 30 (100 %) laboratories
produced a sufficient staining.
rmAb clone SP1, prod. no IR151, Dako: The protocols giving
an optimal result were all based on HIER using TRS pH 9 (EnVision FLEX TRS high pH) for 20 min in the PT-Link,
an incubation time of 20 min in the primary Ab and EnVision Flex
(K8000/K8002) as the detection system. Using these protocol settings
6 out of 7 (86 %) laboratories produced a sufficient staining.
mAb clones 1D5 + ER-2-123, prod. no K1904/SK310, Dako
(pharmDx™ kit): The protocols giving an optimal result were all
based on HIER using TRS pH 6.1 in a pressure
cooker, an incubation time of 20 or 30 min in the primary Ab and
EnVision (K5207/SK310) as the detection system. Using these protocol
settings both of two laboratories produced an optimal staining.
mAb clone 6F11, prod. no 760-2596, Ventana: The protocol
giving an optimal result was based on HIER using Cell Conditioning
1, mild, an incubation time of 32 min in the primary Ab and ultraView as the detection system.
The most frequent causes of an insufficient staining in this run
were:
- Too low concentration of the primary antibody
- Insufficient HIER (use of citrate pH 6.0 and/or too short heating
time)
- Excessive HIER.
In this assessment the prevalent feature of an insufficient staining
was a general too weak reaction or completely false negative reaction
in the ductal carcinomas no. 3 & 4 (which should show 60-80% positivity). As
shown in the previous runs the uterine cervix could be used as an
appropriate control and critical stain quality indicator for the ER
staining. In the optimal protocols almost all epithelial cells
showed a moderate to strong and distinct
nuclear reaction (compared to protocols giving insufficient
results in which both the proportion of positive cells and the
intensity was significantly reduced). In concordance with previous
NordiQC assessments of ER it was observed that the mAb clone 6F11
and the rmAb clone SP1 (both as concentrate and Ready-To-Use)
gave a higher proportion of sufficient results compared to the mAb
clone 1D5. In table 2 the overall performance is listed of the 4
most widely used Abs for ER in the NordiQC assessments. In this
assessment no protocol based on the mAb clone 1D5 resulted in an
optimal staining. When the clone 1D5 was used in an otherwise
correctly calibrated system a moderate to strong aberrant cytoplasmic
staining was seen in the ER negative breast ductal carcinoma no. 2
complicating the interpretation. The majority of the laboratories
are now using efficient HIER based on an alkaline buffer, which in
all assessments has shown to be valuable to
provide an optimal sensitivity for the ER demonstration. However, the
HIER method has to be adjusted to give both a high
sensitivity and an acceptable morphology. In the current run some laboratories obtained an insufficient result due to
excessive HIER (typically a too long heating time
and/or too high temperature).
Table 2. Results for the four most used Abs in seven ER tests in
NordiQC
|
|
All ER
assessments*
All protocol settings |
All ER
assessments*
Optimal protocol settings** |
|
|
Protocols |
Sufficient |
Optimal |
Protocols |
Sufficient |
Optimal |
|
mAb clone 1D5 |
219 |
136 (62%) |
39 (18%) |
109 |
77 (71%) |
39 (36%) |
|
mAb clone 1D5 +
ER-2-123 |
10 |
9 (90%) |
4 (40%) |
10 |
9 (90%) |
4 (40%) |
|
mAb 6F11 |
212 |
161 (76%) |
80 (38%) |
165 |
143 (87%) |
80 (49%) |
|
rmAb SP1 |
161 |
141 (87%) |
103 (64%) |
151 |
141 (93%) |
103 (73%) |
*Runs 8, 10, 13, B1, B3,
B5, B7. ** HIER and dilution range of the Ab in all assessments
giving an optimal result.
This was the 7' assessment of ER in NordiQC breast module and a
relative constant proportion of sufficient results have been
obtained in the last 5 runs as shown in table 3:
Table 3:
Sufficient over-all results with ER in seven NordiQC runs
Conclusion
The mAb clone 6F11 and the rmAb SP1 seem to be the most robust Abs
for ER. HIER is mandatory, preferable in an alkaline buffer and
must be performed to provide an optimal balance between sensitivity
and preserved morphology. The concentration of the Ab must be
carefully calibrated on an appropriate control such as the uterine
cervix in which both the epithelial cells and most stromal cells
must show a moderate-strong distinct nuclear reaction with minimal
cytoplasmic reaction. |